DS
TDAC

David Shaw’s Translational Development Acquisition Corp TDAC Stock Holding History

David Shaw’s Portfolio TDAC Stock Details TDAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-346,900
Closed -$3.66M – 5322
2026
Q1 		$3.66M Hold
346,900
– – ﹤0.01% 2413
2025
Q4 		$3.64M Hold
346,900
– – ﹤0.01% 2578
2025
Q3 		$3.59M Hold
346,900
– – ﹤0.01% 2506
2025
Q2 		$3.57M Buy
+346,900
New +$3.52M ﹤0.01% 2286

Other funds holding TDAC

LA
Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return
KC
Kryger Capital London, United Kingdom $1.75B AUM 102.57% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
MC
Meteora Capital Boca Raton, Florida $1.21B AUM 13.69% 1-Year Est. Return
HCM
Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return
TCM
Tenor Capital Management New York $7.09B AUM 3.55% 1-Year Est. Return
AIMCA
Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $17.9B AUM 27.56% 1-Year Est. Return

David Shaw's TDAC Position: Q2 2026 in Review

David Shaw sold out of Translational Development Acquisition Corp (TDAC) in Q2 2026, closing a stake of 346,900 shares — an estimated $3.66M sold.

David Shaw first reported a position in TDAC in Q2 2025 and held it in 4 quarters. The position peaked at $3.66M in Q1 2026. 35 funds tracked by Wall St. Rank hold TDAC as of Q2 2026.

  • David Shaw reported no remaining Translational Development Acquisition Corp position as of Q2 2026 after selling out during the quarter.
  • David Shaw sold 346,900 Translational Development Acquisition Corp shares in Q2 2026, an estimated $3.66M.
  • David Shaw first reported a position in Translational Development Acquisition Corp in Q2 2025 and held it in 4 quarters.
  • David Shaw's Translational Development Acquisition Corp position peaked at $3.66M in Q1 2026.
  • 35 funds tracked by Wall St. Rank held Translational Development Acquisition Corp as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.